Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
dispose in a sharps container [14]
Long-term safety and efficacy of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week open-label, multicenter, post-marketing clinical study
Dual and triple GLP-1 agonists are next-generation therapies that activate multiple receptors to enhance metabolic effects
Drug-receptor interactions in anaesthesia
However, individual responses to medications vary between individuals
In summary, targeting STAT3 and its related pathways may help prevent the occurrence and progression of inflammatory diseases (Zhao et al., 2021)
US$ 20.53
US$ 25.94
?unique=16ad55f)
US$ 20.19
US$ 27.20
US$ 20.96
US$ 27.65
US$ 23.59
US$ 21.25
US$ 29.31
